JOY GAINOUS: Open Payments
NPI 1861624173 · THOMASVILLE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$902 in 50 payments from 14 companies in 2025. Trend: 2023 $1,202 · 2024 $1,244 · 2025 $902
Food & beverage: $902
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 10 | $242 |
| PFIZER INC. | 11 | $142 |
| AstraZeneca Pharmaceuticals LP | 5 | $93 |
| E.R. Squibb & Sons, L.L.C. | 5 | $83 |
| Novo Nordisk Inc | 4 | $71 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $62 |
| Amgen Inc. | 3 | $53 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 3 | $46 |
| Alnylam Pharmaceuticals Inc. | 1 | $21 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $20 |
Products named: LEQVIO, VYNDAQEL, FARXIGA, CAMZYOS, JARDIANCE, REPATHA, LifeVest, Wegovy.
Industry payments across GA — which companies pay providers there.
